Literature DB >> 23513060

Diverse mediators modulate the chloride ion fluxes that drive lacrimal fluid production.

Shivaram Selvam1, Austin K Mircheff, Samuel C Yiu.   

Abstract

PURPOSE: To learn whether locally expressed and systemic mediators might modulate the cholinergically induced transepithelial Cl(-) fluxes that underlie lacrimal fluid production.
METHODS: Reconstituted epithelial monolayers were exposed to a submaximal dose of the muscarinic agonist, carbachol (CCh), or to one of several paracrine mediators for 18 hours, then acutely stimulated with an optimal dose of CCh. Secretory Cl(-) fluxes were assessed as negative short-circuit currents (ISC).
RESULTS: Exposure to IL-6 at concentrations of 1 and 10 ng/mL and IL-1β at 10 ng/mL significantly decreased CCh-induced Cl(-) secretion. Prolactin decreased CCh-induced Cl(-) secretion, but the extent of the decrease diminished as the prolactin concentration increased from 20 to 200 ng/mL. CCh, 10 μM, prevented CCh, 100 μM, from eliciting Cl(-) secretion. Exposure to histamine, 10 mM, prevented formation of confluent monolayers. Exposure to histamine, 1 mM, decreased CCh-induced Cl(-) secretion, whereas exposure to 5-HT, 1 mM, potentiated CCh-induced Cl(-) secretion.
CONCLUSIONS: Chronic exposure to inflammatory cytokines may significantly impair cholinergically induced lacrimal fluid production. Concentrations of prolactin within the high range of normal values also may impair fluid production, but this effect is reversed at levels associated with pregnancy. Autonomic neurotransmitters and paracrine mediators that signal through different G protein-coupled receptors appear to exert varying influences, which range from complete suppression to potentiation of cholinergically induced fluid production. Thus, some hormones and paracrine mediators may impair secretion in apparently homeostatic glands as well as diseased glands, whereas mediators produced by certain immune cell infiltrates may actually enhance fluid formation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23513060      PMCID: PMC3638659          DOI: 10.1167/iovs.12-10202

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  55 in total

1.  Distribution of growth factors and immune cells are altered in the lacrimal gland during pregnancy and lactation.

Authors:  J Schechter; J Carey; M Wallace; R Wood
Journal:  Exp Eye Res       Date:  2000-08       Impact factor: 3.467

2.  A comparison of the hormone levels in patients with Sjogren's syndrome and healthy controls.

Authors:  S Taiym; N Haghighat; I Al-Hashimi
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2004-05

3.  Prolactin during pregnancy and lactation in the rabbit.

Authors:  A S McNeilly; H G Friesen
Journal:  Endocrinology       Date:  1978-05       Impact factor: 4.736

4.  Role of proinflammatory cytokines in the impaired lacrimation associated with autoimmune xerophthalmia.

Authors:  Driss Zoukhri; Robin R Hodges; Dosek Byon; Claire Larkin Kublin
Journal:  Invest Ophthalmol Vis Sci       Date:  2002-05       Impact factor: 4.799

5.  Mikulicz's disease and Sjögren's syndrome.

Authors:  K Tsubota; H Fujita; K Tsuzaka; T Takeuchi
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-06       Impact factor: 4.799

6.  Lacrimal gland electrolyte and water secretion in the rabbit: localization and role of (Na+ + K+)-activated ATPase.

Authors:  D A Dartt; M Møller; J H Poulsen
Journal:  J Physiol       Date:  1981-12       Impact factor: 5.182

7.  Prevalence of dry eye syndrome among US women.

Authors:  Debra A Schaumberg; David A Sullivan; Julie E Buring; M Reza Dana
Journal:  Am J Ophthalmol       Date:  2003-08       Impact factor: 5.258

8.  Hyperprolactinemia in Sjogren's syndrome: a patient subset or a disease manifestation?

Authors:  Yasser M El Miedany; Ihab Ahmed; Hossam Moustafa; Mohammed El Baddini
Journal:  Joint Bone Spine       Date:  2004-05       Impact factor: 4.929

9.  Biochemical changes contributing to functional quiescence in lacrimal gland acinar cells after chronic ex vivo exposure to a muscarinic agonist.

Authors:  L Qian; Y Wang; J Xie; C M Rose; T Yang; T Nakamura; M Sandberg; H Zeng; J E Schechter; R H Chow; S F Hamm-Alvarez; A K Mircheff
Journal:  Scand J Immunol       Date:  2003-11       Impact factor: 3.487

10.  Lacrimal histopathology and ocular surface disease in a rabbit model of autoimmune dacryoadenitis.

Authors:  Zejin Zhu; Douglas Stevenson; Joel E Schechter; Austin K Mircheff; Roscoe Atkinson; Melvin D Trousdale
Journal:  Cornea       Date:  2003-01       Impact factor: 2.651

View more
  3 in total

1.  Potentially pathogenic immune cells and networks in apparently healthy lacrimal glands.

Authors:  Austin K Mircheff; Yanru Wang; Chuanqing Ding; Dwight W Warren; Joel E Schechter
Journal:  Ocul Surf       Date:  2014-11-06       Impact factor: 5.033

Review 2.  Plasmacytoid dendritic cells in the eye.

Authors:  Arsia Jamali; Brendan Kenyon; Gustavo Ortiz; Abdo Abou-Slaybi; Victor G Sendra; Deshea L Harris; Pedram Hamrah
Journal:  Prog Retin Eye Res       Date:  2020-07-24       Impact factor: 21.198

3.  Multiple Natural and Experimental Inflammatory Rabbit Lacrimal Gland Phenotypes.

Authors:  Austin K Mircheff; Yanru Wang; Joel E Schechter; Meng Li; Warren Tong; Mayssa Attar; Murty Chengalvala; Joe Harmuth; Jeffery J Prusakiewicz
Journal:  Ocul Surf       Date:  2016-07-15       Impact factor: 5.033

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.